person

Makarios E.

Country
Greece
Department
2nd Department of Obstetrics and Gynecology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 17 partner sites.

Specializations

Gynecologic Oncology

Investigator concentrates on malignancies of the female reproductive system, including ovarian cancer, endometrial cancer, fallopian tube neoplasms and peritoneal neoplasms.

  • Platinum‑resistant ovarian cancer
  • High‑grade serous ovarian carcinoma
  • Recurrent endometrial carcinoma
  • Primary peritoneal carcinoma

These efforts target innovative therapeutic strategies for advanced or recurrent disease.

Breast Cancer Therapeutics

Research emphasis lies on hormone‑driven and triple‑negative disease, such as ER+/HER2‑negative breast cancer, triple‑negative breast cancer and hormone receptor‑positive breast cancer.

  • ESR1‑mutated advanced breast cancer
  • Hormone‑resistant breast cancer
  • HER2‑negative metastatic breast cancer
  • Adjuvant endocrine therapy optimization

The work seeks to expand effective options across disease stages and molecular subtypes.

Gastrointestinal Oncology

Focus includes malignancies of the digestive tract, notably colorectal cancer, pancreatic ductal adenocarcinoma and related treatment‑related complications.

  • Chemotherapy‑induced thrombocytopenia
  • Metastatic colorectal cancer
  • KRAS‑mutated colorectal cancer
  • Advanced pancreatic cancer

These studies aim to improve survival and manage therapy‑associated toxicities.

Thoracic and Renal Oncology

Investigator engages in lung and kidney cancer research, covering non‑small cell lung cancer and renal cell carcinoma.

  • EGFR‑mutated NSCLC
  • PD‑L1‑positive NSCLC
  • Advanced renal cell carcinoma
  • Combination immunotherapy regimens

Efforts are directed toward targeted and immune‑based treatment advances.

Obstetric and Maternal Health

Research also addresses pregnancy‑related conditions, particularly preeclampsia prevention.

  • Low‑dose aspirin for preeclampsia prophylaxis
  • Twin pregnancy complications
  • Early‑onset preeclampsia mitigation
  • Maternal cardiovascular risk reduction

These initiatives aim to improve maternal outcomes and reduce pregnancy‑associated morbidity.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.